What’s the deal with Cholesterol? Good, bad, both, myth? Perhaps it is a myth, something that’s been made into a problem so pharmaceutical companies can keep raking in the cash? Statins alone generate billions of dollars a year. The important point to take note of is the fact that Statins, drugs designed to lower ones cholesterol, are one of the biggest drugs prescribed to patients, and one of the biggest earners for pharmaceutical companies, which is concerning.
Why is it concerning? Because over the years, it’s become more and more difficult for people to trust pharmaceutical companies for several different reasons. Whether it’s about studies that continue to expose the harmful effects of various drugs, or the chief editors of Major Medical journals like Dr. Richard Horton (editor in chief of the Lancet )”blowing the whistle,” so to speak, there is large . (1)(2)(3)(4)
Now, a new study recently published in the American Journal of Physiology, states that statins the adverse effects of statins advance the process of aging, and points out that long term use of stats have been associated with several serious adverse health effects including myopathy (skeletal muscle weakness), neurological side effects and an increased risk of diabetes.”
The study outlines the negative effect statins have on mesenchymal stem cells (MSCs), and how they also impaired the expression of DNA repair genes which, the authors believe, proved a “novel explanation for their adverse clinical effects.”
We know that that the ability of these cells to differentiate isn’t good, and statins reduce that which is why improved plaque stability in patients with cardiovascular disease is seen, but we never hear about the detrimental side effects . These side affects are very worrisome, and for many people, it’s a no brainer why statins are not really worth it.
According the the authors of the study:
Considering their possible side effects, long-term adherence to statin treatment poses a potential risk, especially among individuals without cardiovascular disease. The primary use of statins should be critically assessed, especially when considering the potential risks associated with statin use. These are, based on our findings, associated with a negative effect of statins on stem cell properties. In this context, the recently published findings of an increased risk of cataract formation with long-term statin therapy might represent a further clinical side effect potentially attributable to the impact of statins on stem cells and their reduced ability to differentiate into mature differentiated cells
The study was also done on cells in a lab, in vitro, not on a living organism (in vivo). More in vivo studies are warranted.
It’s also important to mention that various studies have been conducted associating the consumption of statin drugs with an increased risk of more than 300 serious and life-threatening side effects, including developing cancer, cataracts, diabetes, cognitive impairment, and musculoskeletal disorders. For instance, one study discovered that, over the course of 10 years of statin therapy, women’s risk of getting invasive ductal carcinoma increased by 83 percent, while their risk of getting invasive lobular carcinoma of the breast skyrocketed to 97 percent.
atin drugs are marketed for their ability to decrease the artery disease called atherosclerosis, they may actually stimulate it and cause heart failure.
In 2012 the Food and Drug Administration even put a warning label on statins for their potential to raise blood glucose levels in people at high risk of Type 2 diabetes.
MIT science graduate, and chemist by training, Raymond Francis has much more to say about statins. He is an internationally recognized leader in the field of optimal health maintenance. To hear more of what he has to say, please watch the video below. Alternative sources have been provided that correlate with the claims made by Francis.
“Studies are confirming the health benefits of meat-free eating. Nowadays, plant-based eating is recognized as not only nutritionally sufficient but also as a way to reduce the risk for many chronic illnesses.” – Harvard Medical School (source)
For example, the American Dietetic Association weighed in with a position paper, concluding that “appropriately planned vegetarian diets, including total vegetarian or vegan diets, are healthful, nutritionally adequate, and may provide health benefits in the prevention and treatment of certain diseases.” (Journal of the American Dietetic Association, July 2009) (source)
These diseases include heart disease, cancer, diabetes, and more.
Again, there are literally a multitude of studies showing the benefits of vegetarian and/or vegan diets. If you are still skeptical, a quick little research session will make the matter abundantly clear.
It’s good to see research into vegetarianism and veganism confirm these benefits, whereas in previous years they focused solely on the problems that can arise from potential nutritional deficiencies. That being said, if you are going to make this transition, it is very important to be aware of your body’s requirements and what nutrients you may be giving up. You will have to learn the plant-based sources of these nutrients.
If this is something you are interested in, we encourage you to further your research. If you try it out, you should not feel tired, lacking energy or strength, or feel depressed. In fact, it should be the exact opposite. If something like this happens to you, you are most likely deficient in nutrients, so make sure to adjust your meals accordingly.
The belief that our ancestors exclusively consumed meat is completely false, and a great example of how many can believe a theory, or have a belief system and accept it as absolute fact when there is evidence to the contrary.
The majority of the food eaten by primates is plant-based, not animal, and there is research suggesting that it’s been that way for a long time. Our ancestors were clearly not the meat-eating caveman that they are so often portrayed to be, and even if they did eat meat, that doesn’t mean that we are genetically wired to do the same:
“It’s difficult to comment on ‘the best diet’ for modern humans because there have been and are so many different yet successful diets in our species. Because some hunter-getherer society obtained most of their dietary energy from wild animal fat and protein does not imply that this is the ideal diet for modern humans, nor does it imply that modern humans have genetic adaptations to such diets.” – Katherine Milton, anthropologist at the University of California, Berkeley (source)
Today, there are a number of papers that’ve been published -in peer-reviewed scientific journals -that have analyzed the diets of a variety of ancient hominin species by looking at their fossilized teeth. These findings have shown that human ancestors ate far more plant material than what was previously suspected.
(1) Bates TR, Connaughton VM, Watts GF. Non-adherence to statin therapy: a major challenge for preventive cardiology. Expert Opin Pharmacother 10: 2973–2985, 2009. CrossRefMedlineWeb of Science Google Scholar
(2) Bouchard MH, Dragomir A, Blais L, Berard A, Pilon D, Perreault S. Impact of adherence to statins on coronary artery disease in primary prevention. Br J amounts of evidence to see why “Big Pharma” is a term that’s no longer considered a “conspiracy theory.”
Statins are taken by one in four Americans over the age of 45, predominately to protect themselves against heart attacks and strokes. The funny thing is, however, is that several studies have shown that statins, when used for primary prevention, have little effect on cardiovascular diseaseClin Pharmacol 63: 698–708, 2007. CrossRefMedlineWeb of ScienceGoogle Scholar
(3) Perreault S, Blais L, Dragomir A, Bouchard MH, Lalonde L, Laurier C, Collin J Persistence and determinants of statin therapy among middle-aged patients free of cardiovascular disease. Eur J Clin Pharmacol 61: 667–674, 2005. CrossRefMedlineWeb of ScienceGoogle Scholar
(4) Perreault SBlais L,Lamarre D,Dragomir A,Berbiche D,Lalonde L, Laurier C,St-Maurice F,CollinJPersistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention. Br J Clin Pharmacol 59: 564–573, 2005. CrossRefMedlineWeb of ScienceGoogle Scholar